Stockscreener 앱 받기
6.69
4.70%
-0.33
시간 외 거래:
6.71
0.02
+0.30%
전일 마감가:
$7.02
열려 있는:
$7.22
하루 거래량:
400.79K
Relative Volume:
4.46
시가총액:
$262.84M
수익:
$4.71M
순이익/손실:
$-46.77M
주가수익비율:
-3.984
EPS:
-1.6792
순현금흐름:
$-60.34M
1주 성능:
-10.32%
1개월 성능:
-11.51%
6개월 성능:
-36.35%
1년 성능:
-18.71%
1일 변동 폭
$6.61
$7.22
1주일 범위
$6.61
$8.5878
52주 변동 폭
$5.55
$11.87
Nyxoah Sa Stock (NYXH) Company Profile
NYXH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
6.69 | 262.84M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
478.19 | 169.15B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
194.96 | 55.18B | 21.39B | 1.59B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.03 | 41.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
283.29 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
239.90 | 17.28B | 2.90B | 467.20M | 306.90M | 6.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-31 | 개시 | H.C. Wainwright | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2022-04-21 | 개시 | Oppenheimer | Outperform |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2021-12-21 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-07-28 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Nyxoah Sa 주식(NYXH)의 최신 뉴스
What recovery options are there for Nyxoah SADaily Equity Signal Strength Summary Report - Newser
Nyxoah SA's (EBR:NYXH) market cap up €31m last week, benefiting both retail investors who own 30% as well as insiders - simplywall.st
Statistical indicators supporting Nyxoah SA’s strengthFree Low Risk Swing Trade Opportunity List - Newser
Smart tools for monitoring Nyxoah SA’s price actionPredictive Analytics for Equity Growth Potential - Newser
FDA Approves Bilateral Neurostimulator for Subset of OSA Patients - Sleep Review
Nyxoah stock surges after FDA approves Genio system for sleep apnea - Investing.com India
Nyxoah revenue jumps 73% to €1.3M in Q2 2025 - Medical Buyer
Cantor Fitzgerald reiterates Overweight rating on Nyxoah stock following FDA approval - Investing.com Nigeria
Visualizing Nyxoah SA stock with heatmapsFree Community Verified Stock Suggestions - Newser
Nyxoah reports preliminary Q2 revenue EUR 1.3M - TipRanks
Nyxoah's FDA Approval and Strategic Shifts: A High-Risk, High-Reward Play in the OSA Market? - AInvest
Nyxoah sees Q2 revenue up 73%, plans R&D shift to U.S. and Belgium; shares rise - Seeking Alpha
Real time social sentiment graph for Nyxoah SABuy Alert Based on RSI and Volume - Newser
Nyxoah SA Trading Near Value Zone — Recovery AheadMarket Surge Signal for Swing Traders Triggered - beatles.ru
FDA Approves Nyxoah's Revolutionary Sleep Apnea Device While Inspire Launches Patent Battle - Stock Titan
How Nyxoah SA stock performs during market volatilityFree Quick Gain Stock Watch With Indicators - Newser
Nyxoah Announces Preliminary Results for the Second Quarter of 2025 - Informazione.it
What are the future prospects of Nyxoah SATrade Picks with 3x Upside - thegnnews.com
Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea - TradingView
FDA Approval: New Genio Sleep Apnea Device Shows 71% Success Rate in Clinical Trials - Stock Titan
When is the best time to buy Nyxoah SA stockFree Opportunity Map for Daily Stock Trading - Newser
Is Nyxoah SA forming a reversal patternHigh Reward Picks with Tight Risk Control - Newser
What drives Nyxoah SA stock priceOverwhelming financial success - Jammu Links News
Is it the right time to buy Nyxoah SA stockStay ahead with daily market updates - Jammu Links News
How does Nyxoah SA generate profit in a changing economyFree Stock Market Query - Jammu Links News
Does Nyxoah SA stock perform well during market downturnsHigh-profit stock alerts - Jammu Links News
What are the latest earnings results for Nyxoah SAFree Daily Trading Room Entry - Jammu Links News
How volatile is Nyxoah SA stock compared to the marketAchieve breakthrough performance with smart picks - Jammu Links News
What is the risk reward ratio of investing in Nyxoah SA stockFree Predictions - Jammu Links News
What markets is Nyxoah SA expanding into Is HTOOW stock a good long term investment optionExplosive returns - Jammu Links News
When is Nyxoah SA stock expected to show significant growthStrongest growth potential - Jammu Links News
Is Nyxoah SA stock overvalued or undervaluedMassive stock growth - Jammu Links News
What are Nyxoah SA company’s key revenue driversMarket-crushing profits - Jammu Links News
How strong is Nyxoah SA company’s balance sheetFree Investment Risk Control - Jammu Links News
Should I hold or sell Nyxoah SA stock in 2025Fastest-growing stock picks - Jammu Links News
What catalysts could drive Nyxoah SA stock higher in 2025Stock Market Forecasts For 2025 - Jammu Links News
Nyxoah Sa (NYXH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.21%
0.06%
자본화:
|
볼륨(24시간):